Interaction between piroxicam and azithromycin during distribution to human periodontal tissues

Journal of Periodontology

Volumn 72, Issue 9, 2001, Pages 1151-1156

  Malizia, Tecla ^a   Batoni, Giovanna ^a   Ghelardi, Emilia ^a   Baschiera, Fabio ^b   Graziani, Filippo ^b   Blandizzi, Corrado ^b   Gabriele, Mario ^b   Campa, Mario ^a   Del Tacca, Mario ^a   Senesi, Sonia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

Azithromycin therapeutic use; Drug administration schedule; Drug distribution; Drug interactions; Infection drug therapy; Pain, postoperative drug therapy; Piroxicam therapeutic use

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; DRUG DETERMINATION; DRUG DISPOSITION; DRUG DISTRIBUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL SURGERY; PERIODONTIUM; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZITHROMYCIN; DRUG COMBINATIONS; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODONTIUM; PIROXICAM; SALIVA; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 18244429752     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.72.9.1151     Document Type: Article

References (22)

1. Longman LP, Martin MV. The use of antibiotics in the prevention of post-operative infection: a re-appraisal. Br Dent J 1991;170:257-262.
2. 2, immunoreactive leukotriene, and pain after periodontal surgery. J Periodontol 1996;67:1307-1316.
3. Howell TH. Blocking periodontal disease progression with anti-inflammatory agents. J Periodontol 1993;64: 828-833.
4. Ng VW-K, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol 1998; 69:772-776.
5. Bollen CM, Quirynen M. Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature. J Periodontol 1996; 67:1143-1158.
6. Walker C, Gordon J. The effect of clindamycin on the microbiota associated with refractory periodontitis. J Periodontol 1990;61:692-698.
7. Olkkola KT, Brunetto AV, Mattila MJ. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin Pharmacokinet 1994;26:107-120.
8. Howell TH, Fiorellini J, Weber HP, Williams RC. Effect of the NSAID piroxicam, topically administered, on the development of gingivitis in beagle dogs. J Periodont Res 1991;26:180-183.
9. Hutchison GL, Crofts SL, Gray IG. Preoperative piroxicam for postoperative analgesia in dental surgery. Br J Anaesth 1990;65:500-503.
10. Selcuk E, Gomel M, Apaydin S, Kose T, Tuglular I. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium. Int J Clin Pharmacol Res 1998;18:21-29.
11. Moore PA. Dental therapeutic indications for the newer long-acting macrolide antibiotics. J Am Dent Assoc 1999;130:1341-1343.
12. Williams JD, Maskell JP, Shain H, et al. Comparative in vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. J Antimicrob Chemother 1992;30:27-37.
13. Malizia T, Tejada MR, Ghelardi E, et al. Periodontal tissue disposition of azithromycin. J Periodontol 1997;68: 1206-1209.
14. Blandizzi C, Malizia T, Lupetti A, et al. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol 1999;70:960-966.
15. Lo Bue AM, Sammartino R, Chisari G, Gismondo MR, Nicoletti G. Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections. J Antimicrob Chemother 1993;31(Suppl. E):119-127.
16. Sefton AM, Maskell JP, Beighton D, et al. Azithromycin in the treatment of periodontal disease. Effect on microbial flora. J Clin Periodontol 1996;23:998-1003.
17. Richardson CJ, Ross SG, Bloka K, Verbeek RK. High-performance liquid chromatografic analysis of piroxicam and its major metabolite 5′-hydroxypiroxicam in human plasma and urine. J Chromatogr 1986;382:382-388.
18. Verbeeck RK, Richardson CJ, Blocka KLN. Clinical pharmacokinetics of piroxicam. J Rheumatol 1986:13:789-796.
19. Haffajee AD, Dibart S, Kent RL, Socransky SS. Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. J Clin Periodontol 1995;22:618-627.
20. Von Rosenstiel N-A, Adam D. Macrolide antibacterials. Drug interactions of clinical significance. Drug Safety 1995;13:105-122.
21. Periti P, Mazzei T, Mini E, Novelli A. Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 1992;23:106-131.
22. Hoepelman IM, Schneider MME. Azithromycin: the first of the tissue-selective azalides. Int J Antimicrob Agents 1995;5:145-167.